Treatment with platelet-derived growth factor which caused vascular smooth muscle cell migration in an MAPK1 activation-dependent manner suggests a role for MAPK1 in the pathogenesis and/or progression of atherosclerosis [42]. The gene discussed is MAPK1; the disease is atherosclerosis.